author_facet Manegold, Christian
Adjei, Alex
Bussolino, Federico
Cappuzzo, Federico
Crino, Lucio
Dziadziuszko, Rafal
Ettinger, David
Fennell, Dean
Kerr, Keith
Le Chevalier, Thierry
Leighl, Natasha
Papotti, Mauro
Paz-Ares, Luis
Pérol, Maurice
Peters, Solange
Pirker, Robert
Quoix, Elisabeth
Reck, Martin
Smit, Egbert
Vokes, Everett
van Zandwijk, Nico
Zhou, Caicun
Manegold, Christian
Adjei, Alex
Bussolino, Federico
Cappuzzo, Federico
Crino, Lucio
Dziadziuszko, Rafal
Ettinger, David
Fennell, Dean
Kerr, Keith
Le Chevalier, Thierry
Leighl, Natasha
Papotti, Mauro
Paz-Ares, Luis
Pérol, Maurice
Peters, Solange
Pirker, Robert
Quoix, Elisabeth
Reck, Martin
Smit, Egbert
Vokes, Everett
van Zandwijk, Nico
Zhou, Caicun
author Manegold, Christian
Adjei, Alex
Bussolino, Federico
Cappuzzo, Federico
Crino, Lucio
Dziadziuszko, Rafal
Ettinger, David
Fennell, Dean
Kerr, Keith
Le Chevalier, Thierry
Leighl, Natasha
Papotti, Mauro
Paz-Ares, Luis
Pérol, Maurice
Peters, Solange
Pirker, Robert
Quoix, Elisabeth
Reck, Martin
Smit, Egbert
Vokes, Everett
van Zandwijk, Nico
Zhou, Caicun
spellingShingle Manegold, Christian
Adjei, Alex
Bussolino, Federico
Cappuzzo, Federico
Crino, Lucio
Dziadziuszko, Rafal
Ettinger, David
Fennell, Dean
Kerr, Keith
Le Chevalier, Thierry
Leighl, Natasha
Papotti, Mauro
Paz-Ares, Luis
Pérol, Maurice
Peters, Solange
Pirker, Robert
Quoix, Elisabeth
Reck, Martin
Smit, Egbert
Vokes, Everett
van Zandwijk, Nico
Zhou, Caicun
ESMO Open
Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
Cancer Research
Oncology
author_sort manegold, christian
spelling Manegold, Christian Adjei, Alex Bussolino, Federico Cappuzzo, Federico Crino, Lucio Dziadziuszko, Rafal Ettinger, David Fennell, Dean Kerr, Keith Le Chevalier, Thierry Leighl, Natasha Papotti, Mauro Paz-Ares, Luis Pérol, Maurice Peters, Solange Pirker, Robert Quoix, Elisabeth Reck, Martin Smit, Egbert Vokes, Everett van Zandwijk, Nico Zhou, Caicun 2059-7029 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1136/esmoopen-2016-000118 Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy ESMO Open
doi_str_mv 10.1136/esmoopen-2016-000118
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9lc21vb3Blbi0yMDE2LTAwMDExOA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9lc21vb3Blbi0yMDE2LTAwMDExOA
institution DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
imprint Elsevier BV, 2016
imprint_str_mv Elsevier BV, 2016
issn 2059-7029
issn_str_mv 2059-7029
language English
mega_collection Elsevier BV (CrossRef)
match_str manegold2016novelactiveagentsinpatientswithadvancednsclcwithoutdrivermutationswhohaveprogressedafterfirstlinechemotherapy
publishDateSort 2016
publisher Elsevier BV
recordtype ai
record_format ai
series ESMO Open
source_id 49
title Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_unstemmed Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_full Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_fullStr Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_full_unstemmed Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_short Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_sort novel active agents in patients with advanced nsclc without driver mutations who have progressed after first-line chemotherapy
topic Cancer Research
Oncology
url http://dx.doi.org/10.1136/esmoopen-2016-000118
publishDate 2016
physical e000118
description
container_issue 6
container_start_page 0
container_title ESMO Open
container_volume 1
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792328435889078272
geogr_code not assigned
last_indexed 2024-03-01T12:53:15.178Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Novel+active+agents+in+patients+with+advanced+NSCLC+without+driver+mutations+who+have+progressed+after+first-line+chemotherapy&rft.date=2016-01-01&genre=article&issn=2059-7029&volume=1&issue=6&pages=e000118&jtitle=ESMO+Open&atitle=Novel+active+agents+in+patients+with+advanced+NSCLC+without+driver+mutations+who+have+progressed+after+first-line+chemotherapy&aulast=Zhou&aufirst=Caicun&rft_id=info%3Adoi%2F10.1136%2Fesmoopen-2016-000118&rft.language%5B0%5D=eng
SOLR
_version_ 1792328435889078272
author Manegold, Christian, Adjei, Alex, Bussolino, Federico, Cappuzzo, Federico, Crino, Lucio, Dziadziuszko, Rafal, Ettinger, David, Fennell, Dean, Kerr, Keith, Le Chevalier, Thierry, Leighl, Natasha, Papotti, Mauro, Paz-Ares, Luis, Pérol, Maurice, Peters, Solange, Pirker, Robert, Quoix, Elisabeth, Reck, Martin, Smit, Egbert, Vokes, Everett, van Zandwijk, Nico, Zhou, Caicun
author_facet Manegold, Christian, Adjei, Alex, Bussolino, Federico, Cappuzzo, Federico, Crino, Lucio, Dziadziuszko, Rafal, Ettinger, David, Fennell, Dean, Kerr, Keith, Le Chevalier, Thierry, Leighl, Natasha, Papotti, Mauro, Paz-Ares, Luis, Pérol, Maurice, Peters, Solange, Pirker, Robert, Quoix, Elisabeth, Reck, Martin, Smit, Egbert, Vokes, Everett, van Zandwijk, Nico, Zhou, Caicun, Manegold, Christian, Adjei, Alex, Bussolino, Federico, Cappuzzo, Federico, Crino, Lucio, Dziadziuszko, Rafal, Ettinger, David, Fennell, Dean, Kerr, Keith, Le Chevalier, Thierry, Leighl, Natasha, Papotti, Mauro, Paz-Ares, Luis, Pérol, Maurice, Peters, Solange, Pirker, Robert, Quoix, Elisabeth, Reck, Martin, Smit, Egbert, Vokes, Everett, van Zandwijk, Nico, Zhou, Caicun
author_sort manegold, christian
container_issue 6
container_start_page 0
container_title ESMO Open
container_volume 1
description
doi_str_mv 10.1136/esmoopen-2016-000118
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9lc21vb3Blbi0yMDE2LTAwMDExOA
imprint Elsevier BV, 2016
imprint_str_mv Elsevier BV, 2016
institution DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275
issn 2059-7029
issn_str_mv 2059-7029
language English
last_indexed 2024-03-01T12:53:15.178Z
match_str manegold2016novelactiveagentsinpatientswithadvancednsclcwithoutdrivermutationswhohaveprogressedafterfirstlinechemotherapy
mega_collection Elsevier BV (CrossRef)
physical e000118
publishDate 2016
publishDateSort 2016
publisher Elsevier BV
record_format ai
recordtype ai
series ESMO Open
source_id 49
spelling Manegold, Christian Adjei, Alex Bussolino, Federico Cappuzzo, Federico Crino, Lucio Dziadziuszko, Rafal Ettinger, David Fennell, Dean Kerr, Keith Le Chevalier, Thierry Leighl, Natasha Papotti, Mauro Paz-Ares, Luis Pérol, Maurice Peters, Solange Pirker, Robert Quoix, Elisabeth Reck, Martin Smit, Egbert Vokes, Everett van Zandwijk, Nico Zhou, Caicun 2059-7029 Elsevier BV Cancer Research Oncology http://dx.doi.org/10.1136/esmoopen-2016-000118 Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy ESMO Open
spellingShingle Manegold, Christian, Adjei, Alex, Bussolino, Federico, Cappuzzo, Federico, Crino, Lucio, Dziadziuszko, Rafal, Ettinger, David, Fennell, Dean, Kerr, Keith, Le Chevalier, Thierry, Leighl, Natasha, Papotti, Mauro, Paz-Ares, Luis, Pérol, Maurice, Peters, Solange, Pirker, Robert, Quoix, Elisabeth, Reck, Martin, Smit, Egbert, Vokes, Everett, van Zandwijk, Nico, Zhou, Caicun, ESMO Open, Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy, Cancer Research, Oncology
title Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_full Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_fullStr Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_full_unstemmed Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_short Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
title_sort novel active agents in patients with advanced nsclc without driver mutations who have progressed after first-line chemotherapy
title_unstemmed Novel active agents in patients with advanced NSCLC without driver mutations who have progressed after first-line chemotherapy
topic Cancer Research, Oncology
url http://dx.doi.org/10.1136/esmoopen-2016-000118